MetaCap

ARS Pharmaceuticals Statistics

NASDAQ: SPRYHealth CareBiotechnology: Pharmaceutical PreparationsUSD

2.96-0.40 (-11.90%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

ARS Pharmaceuticals by the numbers

ARS Pharmaceuticals has a market capitalization of $297.6 million based on 100.53M shares outstanding. With trailing EPS of $-2.01, ARS Pharmaceuticals is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 24.1% below its 50-day average and 56.9% below its 200-day average.

Average daily trading volume is 1.83M shares, or about $5.4 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

SPRY valuation vs. peer median

SPRY compared with the median of 8 peer companies
MetricSPRYPeer medianDifference
Market cap$297.56M$284.22M+5%
Avg. volume1.83M566.12K+223%

Peer median across 8 companies: EVMN, BNTC, GLSI, FULC, RLMD, AVIR, GALT, LRMR.

Valuation

Market cap
$297.56M
Price / sales (latest FY)
3.53
EPS (TTM)
$-2.01

Price and trading

Previous close
3.36
Open
3.28
Day range
2.86 – 3.47
52-week range
2.44 – 13.15
52-week change
-61.00%
Beta
—
Volume
2.78M

Dividends and events

Annual dividend
None

Additional statistics

Market Cap
297.56M
Forward Pe
-3.60
Eps
-2.01
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
13.15
Week52 Low
2.44
Avg Volume
1.83M
Shares Outstanding
100.53M
Ma50
3.90
Ma200
6.87
Earnings Date
Nov 5, 2026
Pct From52w High
-77.49%
Pct From52w Low
21.31%

Related